MoAb was combined to examine HLA expression in placental tissues for all the known forms of the nonclassical HLA-E class I molecules that is important in the maternal immune response during pregnancy. Antibody 3D12 showed that HLA-E peptide binding was correlated with surface expression.
| Inventor | Institute |
|---|---|
| Daniel Geraghty | Fred Hutchinson Cancer Center |
| Cat. #: | 161648 |
|---|---|
| Tool sub type: | Primary antibody |
| Research Fields: | Developmental biology;Immunology |
| Application: | FACS, IP, ELISA, Histology, No Western Blot. |
| Target: | HLA-E class I complexes |
| Reactivity: | Human |
| Clone: | 3D12 |
| Host: | Mouse |
| Class: | Monoclonal |
| Primary citation: | lshitani et al. 2003. Journal of Immunology. 171(3):1376-84. PMID: 12874228 |
| Product description: | MoAb was combined to examine HLA expression in placental tissues for all the known forms of the nonclassical HLA-E class I molecules that is important in the maternal immune response during pregnancy. Antibody 3D12 showed that HLA-E peptide binding was correlated with surface expression. |
|---|---|
| Isotype: | IgG1 |
| Molecular weight: | ~40kDa |
| Target background: | Antibody is used to examine expression in placental tissues for all the known forms of the HLA-E nonclassical class I molecules. |
|---|
| Storage conditions: | The antibody solution should be stored undiluted between 2° C and 8° C, and protected from prolonged exposure to light. Do not freeze.For immediate use, short term storage at 4° C up to two weeks is recommended. For long term storage, divide the solution into volumes of no less than 20 ul for freezing at -20° C or -80° C. The small volume aliquot should provide sufficient reagent for short term use. Freeze-thaw cycles should be avoided. |
|---|---|
| Shipping conditions: | Dry ice |
| References: |
lshitani et al. 2003. Journal of Immunology. 171(3):1376-84.PMID: 12874228 Lee et al. 1998. J. Immunol.?160(10):4951-60. PMID: 9590243 |
|---|
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151015 | Anti-CyclinA [E70.1] |
Key Info
Anti-CyclinA [E70.1]
|
View Tool | |||||||||||||||||||
| 151017 | Anti-MBP [R29.6] |
Key Info
Anti-MBP [R29.6]
|
View Tool | |||||||||||||||||||
| 151025 | Anti-Vascular endothelium [10] |
Key Info
Anti-Vascular endothelium [10]
|
View Tool | |||||||||||||||||||
| 151026 | Anti-FCGR1 [10.1] mAb |
Key Info
Anti-FCGR1 [10.1] mAb
|
View Tool | |||||||||||||||||||
| 151039 | Anti-Integrin aVb3 [23C6] |
Key Info
Anti-Integrin aVb3 [23C6]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.